Cargando…
Overexpression of miR-21-5p as a predictive marker for complete tumor regression to neoadjuvant chemoradiotherapy in rectal cancer patients
BACKGROUND: Neoadjuvant chemoradiotherapy (nCRT) followed by radical surgery is the preferred treatment strategy for locally advanced rectal cancer. However, complete tumor regression is observed in a significant proportion of patients after nCRT, making them ideal candidates for alternative treatme...
Autores principales: | Lopes-Ramos, Camila Miranda, Habr-Gama, Angelita, Quevedo, Bruna de Souza, Felício, Natália Mariana, Bettoni, Fabiana, Koyama, Fernanda Christtanini, Asprino, Paula Fontes, Galante, Pedro Alexandre, Gama-Rodrigues, Joaquim, Camargo, Anamaria Aranha, Perez, Rodrigo Oliva, Parmigiani, Raphael Bessa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4279677/ https://www.ncbi.nlm.nih.gov/pubmed/25496125 http://dx.doi.org/10.1186/s12920-014-0068-7 |
Ejemplares similares
-
The use of personalized biomarkers and liquid biopsies to monitor treatment response and disease recurrence in locally advanced rectal cancer after neoadjuvant chemoradiation
por: Carpinetti, Paola, et al.
Publicado: (2015) -
The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
por: Bettoni, Fabiana, et al.
Publicado: (2019) -
Consolidation chemotherapy during neoadjuvant chemoradiation (CRT) for distal rectal cancer leads to sustained decrease in tumor metabolism when compared to standard CRT regimen
por: Habr-Gama, Angelita, et al.
Publicado: (2016) -
Watch and Wait Approach for Rectal Cancer
por: Cerdan-Santacruz, Carlos, et al.
Publicado: (2023) -
TSC2 rare germline variants in non-tuberous sclerosis patients with neuroendocrine neoplasias
por: Asprino, Paula Fontes, et al.
Publicado: (2017)